Gene · 143471
Papers141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phenotyping of post-fertilization sperm mitophagy determinants discovered in a mammalian gamete-based cell-free system. | Biol Res | 2026 | 42366378 | PubTator, text mining | PubMed |
| The synaptonemal complex: structure, function, and clinical implications†. | Biol Reprod | 2026 | 42059593 | PubTator, text mining | PubMed |
| Integrative analysis of the PSMA family identifies PSMA6 as an adverse prognostic biomarker promoting bladder cancer cell proliferation. | Int J Med Sci | 2026 | 41799753 | PubTator, text mining | PubMed |
| The constitutive 20S proteasome is required for the maintenance and differentiation of spermatogonia in mice. | J Adv Res | 2026 | 41167419 | PubTator, text mining | PubMed |
| Prediction of Immunotherapy Response and Prognostic Outcomes for Patients With Ovarian Cancer Using PANoptosis-Related Genes. | Hum Mutat | 2025 | 41141246 | PubTator, text mining | PubMed |
| Single nucleus transcriptome of a "Super RV" shows increased insulin and angiogenesis signaling. | bioRxiv | 2024 | 38196630 | PubTator, text mining | PubMed |
| Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study. | J Thorac Dis | 2023 | 38249933 | PubTator, text mining | PubMed |
| Editorial for the Special Issue "Genetics and Genomics of Gastrointestinal Cancers: From Prevention to Treatment". | Genes (Basel) | 2023 | 37761961 | PubTator, text mining | PubMed |
| Adhesion-regulating molecule 1 (ADRM1) can be a potential biomarker and target for bladder cancer. | Sci Rep | 2023 | 37684377 | PubTator, text mining | PubMed |
| Synaptonemal Complex in Human Biology and Disease. | Cells | 2023 | 37443752 | PubTator, text mining | PubMed |
| The FLIP-FIGNL1 complex regulates the dissociation of RAD51/DMC1 in homologous recombination and replication fork restart. | Nucleic Acids Res | 2023 | 37439366 | PubTator, text mining | PubMed |
| Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity. | Cell Rep Med | 2023 | 37390828 | PubTator, text mining | PubMed |
| Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes. | Front Oncol | 2023 | 37350936 | PubTator, text mining | PubMed |
| Early Gestational Blood Markers to Predict Preeclampsia Complicating Gestational Diabetes Mellitus. | Diabetes Metab Syndr Obes | 2023 | 37252009 | PubTator, text mining | PubMed |
| TMT-Based Comparative Proteomic Analysis of the Spermatozoa of Buck (Capra hircus) and Ram (Ovis aries). | Genes (Basel) | 2023 | 37239333 | PubTator, text mining | PubMed |
| Proteasome-Associated Proteins, PA200 and ECPAS, Are Essential for Murine Spermatogenesis. | Biomolecules | 2023 | 37189334 | PubTator, text mining | PubMed |
| Multiomics of Bohring-Opitz syndrome truncating ASXL1 mutations identify canonical and noncanonical Wnt signaling dysregulation. | JCI Insight | 2023 | 37053013 | PubTator, text mining | PubMed |
| An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC). | J Hepatocell Carcinoma | 2023 | 37020465 | PubTator, text mining | PubMed |
| Pan-cancer investigation of C-to-U editing reveals its important role in cancer development and new targets for cancer treatment. | Front Oncol | 2023 | 36969056 | PubTator, text mining | PubMed |
| Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study. | BMC Ophthalmol | 2023 | 36899334 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/143471/papers